Headquarters
530 VIRGINIA RD, STE 300, CONCORD, MA 01742-2763, US
CONCORD, MA, US
ADISO THERAPEUTICS INC
From the company
Adiso Therapeutics creates medicines to treat inflammatory diseases, aiming to improve the lives of patients and their families. The company is advancing a pipeline of multi-modal agents with novel mechanisms of action and a precision therapeutic approach, including ADS032, a first-in-class dual inflammasome inhibitor (NLRP1 & NLRP3) small molecule in advanced pre-clinical development for respiratory and dermal inflammation, and ADS024, an orally dosed single-strain live biotherapeutic product.
Products & services offered
Capabilities 2
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.